Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
This grant funds research that integrates machine learning with computational fluid dynamics models to improve orally inhaled drug products.
About this program
The Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) grant supports innovative research aimed at enhancing the development and efficacy of inhaled medications. This initiative is designed for researchers and institutions focused on the intersection of machine learning and drug delivery systems, particularly in the context of respiratory therapies. By leveraging advanced computational techniques, the grant seeks to foster breakthroughs that can lead to more effective inhalation therapies for patients. Eligible applicants include academic institutions, research organizations, and other entities with expertise in computational modeling and machine learning. The grant encourages interdisciplinary collaboration to explore novel approaches that can optimize the design and performance of inhaled drug products. Successful proposals will demonstrate a clear understanding of both the technical aspects of computational fluid dynamics and the practical implications for drug delivery.
Eligibility
Academic institutions, research organizations, and other entities with expertise in computational modeling and machine learning.
Requirements
- Proposals must focus on integrating machine learning with computational fluid dynamics.
- Clinical trials are not allowed under this grant.